Plasminogen activator inhibitor type 2 inhibits tumor necrosis factor alpha-induced apoptosis. Evidence for an alternate biological function
about
Nucleocytoplasmic distribution of the ovalbumin serpin PI-9 requires a nonconventional nuclear import pathway and the export factor Crm1The plasminogen activator inhibitor-2 gene is not required for normal murine development or survivalA mesangium-predominant gene, megsin, is a new serpin upregulated in IgA nephropathyThe serine proteinase inhibitor (serpin) plasminogen activation inhibitor type 2 protects against viral cytopathic effects by constitutive interferon alpha/beta primingInhibition of retinoblastoma protein degradation by interaction with the serpin plasminogen activator inhibitor 2 via a novel consensus motifShort-term cytotoxic effects and long-term instability of RNAi delivered using lentiviral vectorsA redox-sensitive loop regulates plasminogen activator inhibitor type 2 (PAI-2) polymerizationIncreased expression of urokinase plasminogen activator and its cognate receptor in human seminomasGene sets identified with oncogene cooperativity analysis regulate in vivo growth and survival of leukemia stem cells.Picornavirus receptor down-regulation by plasminogen activator inhibitor type 2Silencing of integrated human papillomavirus type 18 oncogene transcription in cells expressing SerpinB2.Gene program for cardiac cell survival induced by transient ischemia in conscious pigs.Characterisation of PAUSE-1, a powerful silencer in the human plasminogen activator inhibitor type 2 gene promoterThe transcription factor C/EBP-β mediates constitutive and LPS-inducible transcription of murine SerpinB2.Nuclear calcium signaling controls expression of a large gene pool: identification of a gene program for acquired neuroprotection induced by synaptic activity.Apigenin Attenuates Atherogenesis through Inducing Macrophage Apoptosis via Inhibition of AKT Ser473 Phosphorylation and Downregulation of Plasminogen Activator Inhibitor-2.Cellular distribution and clinical value of urokinase-type plasminogen activator, its receptor, and plasminogen activator inhibitor-2 in esophageal squamous cell carcinoma.Regulation of the human plasminogen activator inhibitor type 2 gene: cooperation of an upstream silencer and transactivator.Peroxiredoxin 6 delivery attenuates TNF-alpha-and glutamate-induced retinal ganglion cell death by limiting ROS levels and maintaining Ca2+ homeostasis.Inhibition of apoptosis in human tumour cells by the tumour-associated serpin, SCC antigen-1.Radiotherapy diagnostic biomarkers in radioresistant human H460 lung cancer stem-like cells.Increased expression of the urokinase plasminogen activator system by Helicobacter pylori in gastric epithelial cells.Connexins and apoptotic transformationDifferential regulation and predictive potential of MacroH2A1 isoforms in colon cancer.Protein composition of microparticles shed from human placenta during placental perfusion: Potential role in angiogenesis and fibrinolysis in preeclampsiaTLR-induced PAI-2 expression suppresses IL-1β processing via increasing autophagy and NLRP3 degradationAuranofin Suppresses Plasminogen Activator Inhibitor-2 Expression through Annexin A5 Induction in Human Prostate Cancer CellsMycobacterium tuberculosis blocks crosslinking of annexin-1 and apoptotic envelope formation on infected macrophages to maintain virulence.Sumoylation-deficient Prdx6 gains protective function by amplifying enzymatic activity and stability and escapes oxidative stress-induced aberrant Sumoylation.Induction of the plasminogen activator inhibitor-2 in cells expressing the ZNF198/FGFR1 fusion kinase that is involved in atypical myeloproliferative disease.Caspase I-related protease inhibition retards the execution of okadaic acid- and camptothecin-induced apoptosis and PAI-2 cleavage, but not commitment to cell death in HL-60 cells.Suppressors of a host range mutation in the rabbitpox virus serpin SPI-1 map to proteins essential for viral DNA replication.SerpinB2 protection of retinoblastoma protein from calpain enhances tumor cell survival.Human Epididymis Protein 4 Promotes Events Associated with Metastatic Ovarian Cancer via Regulation of the Extracelluar Matrix.SERPINB2 is regulated by dynamic interactions with pause-release proteins and enhancer RNAs.
P2860
Q24291464-9F01F03D-A266-4D1C-B0F3-2140A34F76C7Q24554422-0EC3240D-012E-4AFA-9953-43145CC7CE85Q24564566-8E1DFCB0-D346-4B6C-A605-D3E84ABE5A23Q24647186-B015A6BD-FEBF-4DDE-84AC-1BC5A74BE3B5Q24682801-9AF9BAB1-8A9C-489B-9A17-5F66F5B3874EQ24802565-21025061-EA50-4592-878D-88C97271050AQ31137762-46D6DE0F-3860-4AE4-8C93-3FE42643E05EQ33559079-7D4B2385-1C0F-47DE-8EB2-A4306EE13200Q33622409-198714E9-87AD-484B-869D-752968C87019Q33648918-FB228E39-08F8-4370-AE30-F006C1F5F57BQ33707512-A8127015-CF62-4F66-9F05-53A0F16A575CQ33930977-04114FCC-8A01-402E-8487-7AB8E4F24D38Q33948414-68A49611-B560-4E77-95DE-3E0F0A617AE4Q34614516-CD628830-4220-4219-B795-DC814996CE55Q34997364-9EA5D166-0AC8-4C70-867D-F1FA946E1741Q35550976-D7FD05D1-2765-4920-93BE-4829A17C2AA5Q35745390-CE0826DA-3D07-4A56-BF7C-9D9CD184581AQ35879991-8BBB301C-A307-401F-BEC7-7675E6BF3D6BQ36370793-C8294F23-4922-4C2B-8BDA-FEC5798C9457Q36641395-00AF50CE-0783-4350-A3DF-1CD31F9687B1Q36844321-9C361BE4-A24E-4053-ADF3-741BDA19CE24Q36877314-5271FB25-360D-4446-B2AE-04DEF95549B0Q36946179-3781DF1E-B7AA-4A17-800D-B47E5F1D1CE3Q37030875-2CD0DCA9-01D5-4925-81FE-22255242F5DCQ37146239-AE7AC4DE-B9AD-46AE-B3F0-77D5D830FBAAQ37218466-EF5D8360-508A-4880-B4B9-23D702FE31F8Q37685099-8028ADF7-3665-4247-B058-1C4F776672DFQ37701841-ACD4B328-0726-4C80-89CC-4AC0148D7ED6Q37744859-2377D946-3511-4541-B4AF-D5ADEA14CCBBQ38316836-550C9F61-F572-476F-8E10-BF1C1D784C4FQ40960316-14416B35-98E6-4E7C-90BF-6047BE6AC148Q42117156-6279879E-32EB-45BF-B54B-F12D7BDC9DF0Q43123448-978DCE23-7CCB-4A4E-A46D-5C635E00423EQ49199791-2CD01763-D7D0-4F0D-A0CD-D2810CD9286FQ50960691-B89B62C0-4D2E-4689-9C11-9F60A3B7EE7D
P2860
Plasminogen activator inhibitor type 2 inhibits tumor necrosis factor alpha-induced apoptosis. Evidence for an alternate biological function
description
1995 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
article publié dans la revue scientifique Journal of Biological Chemistry
@fr
artículu científicu espublizáu en 1995
@ast
im November 1995 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 1995/11/17)
@sk
vědecký článek publikovaný v roce 1995
@cs
wetenschappelijk artikel (gepubliceerd op 1995/11/17)
@nl
наукова стаття, опублікована в листопаді 1995
@uk
name
Plasminogen activator inhibito ...... alternate biological function
@ast
Plasminogen activator inhibito ...... alternate biological function
@en
Plasminogen activator inhibito ...... alternate biological function
@nl
type
label
Plasminogen activator inhibito ...... alternate biological function
@ast
Plasminogen activator inhibito ...... alternate biological function
@en
Plasminogen activator inhibito ...... alternate biological function
@nl
prefLabel
Plasminogen activator inhibito ...... alternate biological function
@ast
Plasminogen activator inhibito ...... alternate biological function
@en
Plasminogen activator inhibito ...... alternate biological function
@nl
P2093
P1476
Plasminogen activator inhibito ...... alternate biological function
@en
P2093
A. Ferrante
E. J. Bates
J. L. Dickinson
T. M. Antalis
P304
27894–27904
P407
P577
1995-11-17T00:00:00Z